Literature DB >> 3951997

Highly efficient oligodeoxyribonucleotide synthesis using fully base protected phosphodiester building blocks carrying 2-(1-methylimidazol-2-yl) phenyl protection of the phosphate.

B S Sproat, P Rider, B Beijer.   

Abstract

Four fully base protected phosphodiester building blocks have been synthesised and fully characterised. The phosphate protecting group used was the 2-(1-methylimidazol-2-yl)phenyl group, enabling intramolecular catalysis of the condensation step in oligodeoxyribonucleotide synthesis by the solid phase phosphotriester method. Cycle times of about 12 min could thus be achieved. Moreover, the used of extra protecting groups on deoxythymidine and 2'-deoxyguanosine resulted in much cleaner oligodeoxyribonucleotides as evidenced by ion-exchange and reversed phase h.p.l.c.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3951997      PMCID: PMC339575          DOI: 10.1093/nar/14.4.1811

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  11 in total

1.  A new linkage for solid phase synthesis of oligodeoxyribonucleotides.

Authors:  B S Sproat; D M Brown
Journal:  Nucleic Acids Res       Date:  1985-04-25       Impact factor: 16.971

2.  A rapid deprotection procedure for phosphotriester DNA synthesis.

Authors:  T P Patel; M A Chauncey; T A Millican; C C Bose; M A Eaton
Journal:  Nucleic Acids Res       Date:  1984-09-11       Impact factor: 16.971

3.  New effective method for the synthesis of oligonucleotides via phosphotriester intermediates.

Authors:  V A Efimov; S V Reverdatto; O G Chakhmakhcheva
Journal:  Nucleic Acids Res       Date:  1982-11-11       Impact factor: 16.971

4.  Modification of guanine bases by nucleoside phosphoramidite reagents during the solid phase synthesis of oligonucleotides.

Authors:  R T Pon; M J Damha; K K Ogilvie
Journal:  Nucleic Acids Res       Date:  1985-09-25       Impact factor: 16.971

5.  Rapid synthesis of long-chain deoxyribooligonucleotides by the N-methylimidazolide phosphotriester method.

Authors:  V A Efimov; A A Buryakova; S V Reverdatto; O G Chakhmakhcheva
Journal:  Nucleic Acids Res       Date:  1983-12-10       Impact factor: 16.971

6.  Studies on transfer ribonucleic acids and related compounds. XLV. Block condensation of ribooligonucleotides containing 2'-O-tetrahydrofuranyl-5'-O-dimethoxytritylnucleosides.

Authors:  E Ohtsuka; A Yamane; M Ikehara
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

7.  Methylation of thymine residues during oligonucleotide synthesis.

Authors:  X Gao; B L Gaffney; M Senior; R R Riddle; R A Jones
Journal:  Nucleic Acids Res       Date:  1985-01-25       Impact factor: 16.971

8.  Rapid synthesis of oligodeoxyribonucleotides. VII. Solid phase synthesis of oligodeoxyribonucleotides by a continuous flow phosphotriester method on a kieselguhr-polyamide support.

Authors:  M J Gait; H W Matthes; M Singh; B S Sproat; R C Titmas
Journal:  Nucleic Acids Res       Date:  1982-10-25       Impact factor: 16.971

9.  Dialkylformamidines: depurination resistant N6-protecting group for deoxyadenosine.

Authors:  B C Froehler; M D Matteucci
Journal:  Nucleic Acids Res       Date:  1983-11-25       Impact factor: 16.971

10.  Simplications in the synthesis of short oligonucleotide blocks.

Authors:  C Broka; T Hozumi; R Arentzen; K Itakura
Journal:  Nucleic Acids Res       Date:  1980-11-25       Impact factor: 16.971

View more
  2 in total

1.  Solid phase synthesis of oligoribonucleotides using the o-nitrobenzyl group for 2'-hydroxyl protection and H-phosphonate chemistry.

Authors:  T Tanaka; S Tamatsukuri; M Ikehara
Journal:  Nucleic Acids Res       Date:  1987-09-25       Impact factor: 16.971

2.  Application of new catalytic phosphate protecting groups for the highly efficient phosphotriester oligonucleotide synthesis.

Authors:  V A Efimov; A A Buryakova; I Y Dubey; N N Polushin; O G Chakhmakhcheva
Journal:  Nucleic Acids Res       Date:  1986-08-26       Impact factor: 16.971

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.